bionanogenomics.com (BNGO) Bozor kapitallashuvining balans qiymatiga nisbati
Bionano Genomics, Inc. (BNGO) mutatsiyalarni aniqlash uchun avtomatlashtirilgan DNK xaritalash tizimlarini ishlab chiqadi. Og'ir uskunalarning qimmat havo transporti diagnostika aniqligini ta'minlaydi, hozirgi modeldagi o'zgarishlar esa dasturiy ta'minot orqali xarajatlarni kamaytirishga qaratilgan. GURU.Markets platformasidagi kompaniyaning bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati aktivlar baholash dinamikasini aks ettiradi, bunda 0.45 qiymati ushbu darajani xarakterlaydi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_BNGO_-_Bionano-Genomics-Inc._-_Capitalization-to-Book-Value-Ratio "BNGO: Bionano Genomics Inc. Bozor qiymatining balans qiymatiga nisbati 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
Bionano Genomics, Inc. (BNGO) moliyaviy va bozor koʻrsatkichlari kesimi
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Bionano Genomics, Inc.|BNGO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati bionanogenomics.com|BNGO - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Bionano|BNGO - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Bionano Genomics|Tezkor likvidlik koeffitsiyenti bionanogenomics.com
- foyda va bozor multiplikatorlari tafsilotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) yagona genomik xaritalash texnologiyasidagi tor ixtisoslashuvi tufayli xavflarga duch kelmoqda. Kompaniyaning P/BV koeffitsiyenti tarixi aktivning bozor qiymati uning sof balans qiymatidan qanchalik yuqori ekanligini ko'rsatadi. Ushbu koeffitsiyent bozor talabini moddiy kapital bilan solishtirish orqali kutilayotgan o'sish uchun qo'shimcha qiymatni o'lchaydi. Yuqori qiymatlar kelajakdagi muvaffaqiyatning spekulyativ haddan tashqari baholanganligini anglatadi. Investorlar uchun ushbu farqni mahsulotning joriy etilish darajasi bilan bog'lash juda muhimdir.
Raqobatdosh kompaniyalar tahlili
Tempus Labs (TEM) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti qiagen.com (QGEN)|IONS (Ionis) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati RGEN (Repligen Corp)|Bozor qiymatining balans qiymatiga nisbati Avidity (RNA)|CRISPR - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|Beam Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|SRPT: Bozor qiymatining balans qiymatiga nisbati|TWST: Bozor kapitallashuvining balans qiymatiga nisbati|TXG - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Intellia Therapeutics|Bozor qiymatining balans qiymatiga koeffitsiyenti stoketherapeutics.com STOK|Bozor qiymatining balans qiymatiga nisbati BioLife Solutions (BLFS)|Wave Life Sciences Ltd - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati MAZE (Maze Tx)|Bozor kapitallashuvining balans qiymatiga nisbati Sionna Corp SION|PRME - Bozor qiymatining balans qiymatiga nisbati|TSHA (tayshagtx.com) - Kapitallashuvning balans qiymatiga nisbati|uniQure (QURE) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti MeiraGTx Holdings (MGTX)|Kapitallashuvning sof aktivlarga nisbati RGNX|SLDB: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati OCGN|pacb.com (PACB) - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati BNTC (Benitec Biopharma)|Design Therapeutics Inc (DSGN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|RCKT - Bozor qiymatining balans qiymatiga nisbati|FDMT (4D Molecular Corp) - Kapitallashuvning balans qiymatiga nisbati|lexeotx.com (LXEO) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Korro Bio (KRRO)|Bozor qiymatining balans qiymatiga nisbati Editas Medicine|Kapitallashuvning sof aktivlarga nisbati Silence Therapeutics PLC (SLN)|Bozor kapitallashuvining balans qiymatiga nisbati PRQR|Balans qiymatiga nisbatan bozor kapitallashuvi codexis.com|Bozor kapitallashuvining balans qiymatiga nisbati SGMO (Sangamo Therapeutics)|NAUT - Kapitallashuvning sof aktivlarga nisbati|MGX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi precisionbiosciences.com DTIL|GBIO (generationbio.com) - Kapitallashuvning sof aktivlarga nisbati|Boundless Bio Inc - Balans qiymatiga nisbatan bozor qiymati|XCUR (Exicure Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Celsion Corporation (IMNN) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Phio Pharmaceuticals (PHIO)|mustangbio.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RNAZ (TransCode Therapeutics, Inc.)|APDN - Kapitallashuvning sof aktivlarga nisbati|BLUE: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ImmunoPrecise Antibodies IPA|OMGA: Bozor kapitallashuvining balans qiymatiga nisbati|OMIC (Singular Genomics Systems, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regulus Therapeutics Inc|Kapitallashuvning balans qiymatiga nisbati SYRS (Syros Pharmaceuticals, Inc)|Bozor kapitallashuvining balans qiymatiga nisbati TBIO|traconpharma.com (TCON) - Bozor qiymatining xususiy kapitalga nisbati|Bozor qiymatining balans qiymatiga nisbati Unity Biotechnology, Inc. UBX